1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $30,000,000 for Year 1, subject to the availability of funds. This NOFO aims to support Zimbabwe’s Ministry of Health and Child Care (MOHCC) in the provision of innovative and sustainable HIV prevention, testing, counseling, treatment, monitoring, care, support, and retention. It targets all populations, including priority populations (PPs), key populations (KPs), and other sub-populations to achieve 95-95-95 goals (95% of people living with HIV (PLHIV) know their status, 95% of known PLHIV on treatment, and 95% of those on treatment virally suppressed). Supported prevention activities include dissemination of health information and education, HIV pre-exposure prophylaxis (PrEP), and other HIV bio-medical prevention interventions. Collaboration with other partners to support Determined, Resilient, Empowered, AIDS-free, Mentored and Safe (DREAMS) program and services for KPs and PPs is expected. HIV clinical cascade support includes high-yield case finding strategies, ART initiation, continuity of care, viral load (VL) monitoring, management of advanced HIV disease (AHD), services for TB and other co-infections or chronic conditions, cervical cancer screening and treatment, and provision of evidence-based differentiated service delivery (DSD) models. The recipient(s) will also support Elimination of Mother to Child Transmission (eMTCT) efforts. Implementation will be in selected PEPFAR/CDC-supported provinces, subject to change with changing disease burden, programming gaps, priorities, and PEPFAR guidance.
Funding Opportunity Number: CDC-RFA-GH-23-0018. Assistance Listing: 93.067. Funding Instrument: CA. Category: HL.
Get alerted about grants like this
Get emailed when new opportunities from “Centers for Disease Control - CGH” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Eligible applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility. Confirm the full requirements in the official notice before applying.
The published deadline was March 13, 2023, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Yes — Sustainable, Innovative, and Agile Community and Facility HIV Prevention, Care and Treatment Services for Epidemic Control among all Populations in Zimbabwe under the President’s Emergency Plan for AIDS Relief (PEPFAR) is offered by Centers for Disease Control - CGH and this listing comes from Grants.gov, an official U.S. federal source. Federal applications generally require registrations (for example SAM.gov or an agency submission portal), so allow extra lead time.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
NYFIC $10,000 Grants for Sustainable Textile Innovation is a grant from the New York Fashion Innovation Center (NYFIC) that funds New York State–based businesses, organizations, and individuals working to advance and scale sustainable textile development for fashion and interiors. The program supports farmers, researchers, manufacturers, designers, brands, retailers, and educators whose projects contribute to a more sustainable textile industry in New York State. All funded projects must be conducted primarily within New York State. Awards are up to $10,000 per recipient. This biannual grant program runs through 2027, with Round Four opening April 13, 2026, and the application deadline on June 1, 2026. Recipients are announced in the spring following each submission cycle.
Training and innovation networks for sustained capacity development related to ethics, regulatory, pharmacovigilance, and related digital regulatory platforms is sponsored by European Commission — Horizon Europe. Expected Impact: Expected Impact Through strategic capacity building, digital transformation, and cooperation in SSA, the actions funded under this topic should contribute to the establishment of a resilient and future-ready ethics, regulatory and PV environment. Applicant consortium If requested by the applicant consortia, the EDCTP Association may offer technical support for the preparation of their proposal, in particular because of the lump sum nature of the Grant Agreement. The applicant consortia may also decide to include the EDCTP Association as coordinator. In that case, the applicant consortia should contact the EDCTP Association to obtain the estimated amount of the Association’s contribution as well as any other relevant information. The EDCTP Association will timely provide the necessary information to all potential applicants. Expected Outcome: Background Ethics bodies, regulatory agencies, and pharmacovigilance (PV) systems in sub-Saharan Africa (SSA) continue to face significant challenges that hinder effective provision of healthcare services, safety reporting and timely regulatory approval for clinical trials, and marketing authorisation of products. These challenges are largely attributed to limited resources, limited training provision and access to mentor expertise, governance constraints, disparities in digital infrastructure, and limited regional and international regulatory alignment. In response, initiatives such as the African Vaccines Regulatory Forum (AVAREF), the African Medicines Regulatory Harmonization (AMRH) Programme and most recently the African Medicines Agency (AMA) have been launched to address these gaps. International bodies, including the World Health Organization (WHO), along with partnerships in SSA, have contributed to bridge the gap by offering technical support, training, and resources to strengthen ethics, regulatory and PV capacities. Public-private partnerships have further supported ethics and regulatory capacity strengthening, safety monitoring systems, including the development and integration of digital health technologies to enhance adverse event monitoring and reporting, and to accelerate the regulatory submission and assessment processes through collaborative or joint reviews. As per the WHO publication of October 2025 [1] , eight SSA National Regulatory Authorities (NRAs)—Ghana, Nigeria, South Africa, Tanzania, Rwanda, Senegal, and Zimbabwe—are classified by WHO as Maturity Level 3 (ML3), indicating reasonably established and functioning regulatory systems. Nevertheless, major hurdles remain, such as the lack of harmonised regulatory standards and timelines, underfunded research ethics committees (RECs) and NRAs, disparities in institutional and digital capacity and sustainability of the systems set up. These issues hinder the timely and consistent evaluation of research protocols and/or applications for marketing authorisation for diagnostics, medicines, and vaccines across the region. Despite the increasing participation of SSA countries in the WHO Programme for International Drug Monitoring (WHO PIDM), PV systems in many SSA countries remain underdeveloped and insufficiently integrated into national healthcare systems. This is reflected on both pre- and post-authorisation safety monitoring, where systems are weakened by poor digital infrastructure, limited laboratory capacity for confirmation of suspected events, weak reporting tools for data capture and interpretation, and a shortage of trained personnel. This limits the region’s ability to ensure effective PV and safety of medicinal products. Building on the progress made through previous EDCTP initiatives [2] , this call aims to scale and sustain these efforts by establishing training, twinning, and innovation networks, leveraging existing networks where applicable that will bolster workforce capacity in ethics, regulatory, and PV and harmonisation of processes and timelines. Central to this approach is the develop Programme areas: Horizon Europe (HORIZON), Global Challenges and European Industrial Competitiveness, Health Keywords: Artificial intelligence, Big data, Digital Services and Platforms, Digital transformation, Epidemiology, Ethics in medical sciences, Global health, Health data, Health sciences, Medical biotechnology related ethics, Medical ethics, Pharmacovigilance, Regulatory affairs, eInfrastructure, Africa, Africa CDC, Artificial Intelligence, Digital health, Digital health systems, Digital innovations, EDCTP, EDCTP3, Global Health, Innovation networks, Public health, Public health workforce, Regulatory platforms, Skilled personnel, Sub-Saharan Africa, Trainings, Twinning
Training and innovation networks for sustained capacity development related to ethics, regulatory, pharmacovigilance, and related digital regulatory platforms (HORIZON-JU-GH-EDCTP3-2026-03-SERP-01) is sponsored by Global Health EDCTP3 Joint Undertaking. This Coordination & Support Action (CSA) call, under the Global Health EDCTP3 Work Programme 2026, supports training and capacity-building activities in ethics, regulatory affairs, pharmacovigilance, and associated digital regulatory platforms.
HUD announced the FY25 Rural Capacity Building NOFO on May 18, 2026 with a July 6 deadline. Section 4 has three statutory intermediaries — Enterprise, LISC, and Habitat. RCB is a different door, and most rural housing nonprofits are misreading which one they qualify for.
Read articleThe CDC's Notice of Funding Opportunity CDC-RFA-JG-26-0056, Continuing to Enhance Global Health Security, closes for applications on June 25, 2026, with $75 million on the table and eight cooperative agreements anticipated. The NOFO sits inside an unusually compressed window for global health implementing partners — after the USAID dismantling and the 2025 CDC reorganization, this is one of the largest remaining flexible federal vehicles for outbreak-prevention work executed through bilateral partnerships with foreign health ministries. Here is what the solicitation requires, why the eligibility design favors specific applicant types, and what to do if you are still considering whether to apply.
Read articleWhile science funding cuts dominate headlines, the FY2027 budget proposes a $15.8 billion cut to HHS, eliminates hospital preparedness and family planning programs, cuts CDC by $3 billion, and consolidates behavioral health grants into a $4.5 billion mega-block-grant. The definitive breakdown for public health grant seekers.
Read article